JavaScript Explicit Resource Management lands in Safari Technology Preview 250, completing cross-browser support across V8, ...

If you want to capture the sun’s power with solar panels, these are the best solar generators I’ve tested. Save this story Save this story It's easier and more affordable than ever to capture and ...

CryptoJS's weak RNG made recovery phrases guessable across five wallet apps, enabling Ill Bloom thefts totaling at least $5.69 million in two sweeps.

SpaceX’s Starship suffered an abort at T-0 July 16 when some of its Raptor engines failed to ignite. Credit: SpaceX webcast WASHINGTON — SpaceX aborted the launch of its latest Starship test flight ...

Matthew Rodriguez is a digital producer for CBS Los Angeles. He's previously reported for local outlets like the Argonaut and Pasadena Weekly. Matt typically covers breaking news and crime. Julie ...

As more and more data centers are proposed throughout the region and the state, the issues critics bring to the table are becoming fairly familiar — the amount of water used to cool the servers, air ...

Has Elon Musk given up on Tesla’s Master Plans, on the electrified economy, on solar power as we know it? From the SpaceX IPO filing released this week, it sure seems like it. A recap for those not ...

Pragmata's map is bigger and more full of secrets than you might expect from what initially seems like a series of hallways. Nooks filled with danger and crannies hiding treasure abound, but it's easy ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...